199 related articles for article (PubMed ID: 8581873)
1. Increasing serum osteocalcin after glycemic control in diabetic men.
Sayinalp S; Gedik O; Koray Z
Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
[TBL] [Abstract][Full Text] [Related]
2. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
4. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus.
Nagasaka S; Murakami T; Uchikawa T; Ishikawa SE; Saito T
Endocr J; 1995 Jun; 42(3):377-83. PubMed ID: 7670567
[TBL] [Abstract][Full Text] [Related]
5. Bone densitometry and biochemical bone remodeling markers in type 1 diabetes mellitus.
Olmos JM; Pérez-Castrillón JL; García MT; Garrido JC; Amado JA; González-Macías J
Bone Miner; 1994 Jul; 26(1):1-8. PubMed ID: 7950501
[TBL] [Abstract][Full Text] [Related]
6. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Kurioka S; Yano S; Sugimoto T
J Clin Endocrinol Metab; 2009 Jan; 94(1):45-9. PubMed ID: 18984661
[TBL] [Abstract][Full Text] [Related]
7. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes.
Inaba M; Nishizawa Y; Mita K; Kumeda Y; Emoto M; Kawagishi T; Ishimura E; Nakatsuka K; Shioi A; Morii H
Osteoporos Int; 1999; 9(6):525-31. PubMed ID: 10624460
[TBL] [Abstract][Full Text] [Related]
8. Relationships between serum osteocalcin levels versus blood glucose, insulin resistance and markers of systemic inflammation in central Indian type 2 diabetic patients.
Sarkar PD; Choudhury AB
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1631-5. PubMed ID: 23832730
[TBL] [Abstract][Full Text] [Related]
9. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?
Gregorio F; Cristallini S; Santeusanio F; Filipponi P; Fumelli P
Diabetes Res Clin Pract; 1994 Feb; 23(1):43-54. PubMed ID: 8013262
[TBL] [Abstract][Full Text] [Related]
10. Heterotopic ossification. The utility of osteocalcin in diagnosis and management.
Mysiw WJ; Tan J; Jackson RD
Am J Phys Med Rehabil; 1993 Aug; 72(4):184-7. PubMed ID: 8363811
[TBL] [Abstract][Full Text] [Related]
11. Assessment of bone turnover in the dry period of dairy cows by measurement of plasma bone GLA protein, total plasma alkaline phosphatase activity and urinary hydroxyproline.
van Mosel M; Corlett SC
Exp Physiol; 1990 Nov; 75(6):827-37. PubMed ID: 2271160
[TBL] [Abstract][Full Text] [Related]
12. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications.
Pietschmann P; Schernthaner G; Woloszczuk W
Diabetologia; 1988 Dec; 31(12):892-5. PubMed ID: 3266486
[TBL] [Abstract][Full Text] [Related]
13. Study of bone loss in diabetes mellitus type 1.
Leon M; Larrodera L; Lledo G; Hawkins F
Diabetes Res Clin Pract; 1989 Apr; 6(3):237-42. PubMed ID: 2785908
[TBL] [Abstract][Full Text] [Related]
14. Biochemical relationships between bone turnover markers and blood glucose in patients with type 2 diabetes mellitus.
Hussein RM
Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S369-S372. PubMed ID: 28283396
[TBL] [Abstract][Full Text] [Related]
15. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamauchi M; Yamamoto M; Kurioka S; Yano S; Sugimoto T
Osteoporos Int; 2011 Jan; 22(1):187-94. PubMed ID: 20165834
[TBL] [Abstract][Full Text] [Related]
16. [Selected indicators of calcium-phosphate metabolism in patients with diabetes mellitus].
Błasiak M; Kuska J; Kokot F; Irzyniec T
Endokrynol Pol; 1989; 40(5):251-62. PubMed ID: 2641514
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
18. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion.
Topaloglu AK; Yildizdas D; Yilmaz HL; Mungan NO; Yuksel B; Ozer G
Bone; 2005 Jul; 37(1):122-7. PubMed ID: 15869925
[TBL] [Abstract][Full Text] [Related]
19. Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.
Prelević GM; Beljić T; Balint-Perić L; Petrović J; Elliesen J
Gynecol Endocrinol; 1994 Sep; 8(3):209-14. PubMed ID: 7847107
[TBL] [Abstract][Full Text] [Related]
20. Metabolic improvement of poorly controlled noninsulin-dependent diabetes mellitus decreases bone turnover.
Okazaki R; Totsuka Y; Hamano K; Ajima M; Miura M; Hirota Y; Hata K; Fukumoto S; Matsumoto T
J Clin Endocrinol Metab; 1997 Sep; 82(9):2915-20. PubMed ID: 9284719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
